Literature DB >> 24047689

Adverse drug reactions as a reason for admission to an internal medicine ward in Argentina.

Paulino A Alvarez1, Fernando Bril, Verónica Castro, Itati Meiville, Claudio D Gonzalez, Ignacio Gomez Centurion, Griselda Parejas, Cristina Soler Riera, Cristian Lopez Saubidet, Guillermo Di Girolamo, Guillermo A Keller.   

Abstract

BACKGROUND: Adverse Drug Reactions (ADR) are a major cause of morbidity and mortality worldwide. In spite of this, ADR are largely underreported and unrecognized.
PURPOSE: Identify and characterize ADR related admissions to our internal medicine ward using a proactive multidisciplinary pharmacovigilance approach.
METHODS: Within 24 hrs of admission 1045 patients admitted to the Internal Medicine Ward between August 2010 and February 2012 were screened for possible or probable ADR related admissions.
RESULTS: Probable ADR accounted for 112 of 1045 admissions (10.7%, 95% Confidence Interval [CI]: 8.8-12.6%), of which only 16 (14.3%) were classified as unavoidable. NSAIDs were the drug group more commonly implicated in probable ADR-related admissions (17.0%), followed by antiplatelets (16.1%). In-hospital mortality of patients admitted due to probable ADR was 8.0% (95% CI: 2.9-13.1%). During this study period, 6% of internal medicine ward and 4% of critical care unit beds were occupied by patients with probable ADR. The estimated cost of care of these patients was 641,000 US dollars (USD).
CONCLUSION: ADR are a frequent reason for admission to an Internal Medicine Ward in Argentina. The culprit drugs and interactions are similar to those reported in the literature. The cost is substantial and most of the ADR are potentially avoidable.

Entities:  

Mesh:

Year:  2013        PMID: 24047689     DOI: 10.3233/JRS-130596

Source DB:  PubMed          Journal:  Int J Risk Saf Med        ISSN: 0924-6479


  7 in total

1.  Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis.

Authors:  Tejas K Patel; Parvati B Patel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-19       Impact factor: 2.953

Review 2.  Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors.

Authors:  Mulugeta Tarekegn Angamo; Leanne Chalmers; Colin M Curtain; Luke R E Bereznicki
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.606

3.  Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa.

Authors:  Johannes P Mouton; Christine Njuguna; Nicole Kramer; Annemie Stewart; Ushma Mehta; Marc Blockman; Melony Fortuin-De Smidt; Reneé De Waal; Andy G Parrish; Douglas P K Wilson; Ehimario U Igumbor; Getahun Aynalem; Mukesh Dheda; Gary Maartens; Karen Cohen
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

4.  Unplanned readmissions in younger and older adult patients: the role of healthcare-related adverse events.

Authors:  Fabienne J H Magdelijns; Larissa Schepers; Evelien Pijpers; Coen D A Stehouwer; Patricia M Stassen
Journal:  Eur J Med Res       Date:  2016-09-15       Impact factor: 2.175

5.  Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.

Authors:  Mulugeta Tarekegn Angamo; Colin Michael Curtain; Leanne Chalmers; Daniel Yilma; Luke Bereznicki
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

6.  City-wide electronic health records reveal gender and age biases in administration of known drug-drug interactions.

Authors:  Rion Brattig Correia; Luciana P de Araújo Kohler; Mauro M Mattos; Luis M Rocha
Journal:  NPJ Digit Med       Date:  2019-07-23

7.  Ten-year trends in adverse drug reaction-related hospitalizations among people with dementia.

Authors:  Anum Saqib Zaidi; Gregory M Peterson; Luke R E Bereznicki; Colin M Curtain; Mohammed S Salahudeen
Journal:  Ther Adv Drug Saf       Date:  2022-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.